InsightRX Continuous Learning
Your Partner in Clinical Innovation and Practice Improvement
- Home
- Platform
- InsightRX Continuous Learning
Our patented framework ensures that models evolve with real-world data and improve continually over time

Other precision dosing tools remain the same after implementation. Ours doesn’t.
InsightRX is the first and only healthcare technology company to hold a US Patent (No. 11,075,010 B1) for our model improvement and retraining processes.
Model optimization is based on distributed data acquisition and continuously refines dosing predictions using real-world data.
Tailor predictive models to your population
Pharmacology models trained on broad populations often miss key nuances in specific patient groups. InsightRX continuously retrains models using your real-world clinical data — enhancing predictive accuracy for your unique population and driving better dosing decisions.
Lead the expansion of precision dosing at your organization
Join the forefront of clinical innovation and learn how your team can help develop and implement new precision dosing modules and advance safe, effective medication management across your enterprise.
Keep models accurate with minimal effort
Predictive model performance degrades without regular updates. InsightRX automates model monitoring and retraining, detecting drift and maintaining accuracy — so you stay current without extra burden on your clinical or IT teams.
The system dropped our rate of kidney injury for patients on certain antibiotics. Our estimate is that the system ultimately saves us hundreds of thousands of dollars a year, and that may change more as we use it more.
- KLAS Spotlight Report, Pharmacy Manager
Case Study
Additional Information
Learn more about our products and services:
Leverage Fully-Validated Drug Modules
Enhance dosing precision with InsightRX’s extensive library of pharmacokinetic and pharmacodynamic drug modules, rigorously validated to support individualized therapy across diverse patient populations.
Utilize the Gold-Standard in Bayesian MIPD
Individualize therapy with Bayesian dosing support that adapts to each patient. InsightRX Nova clinical decision software helps you personalize doses at the point of care, reaching therapeutic targets faster and helping clinicians proactively reduce adverse drug events.